Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Authors :: van den Beukel, Michelle D.
van Wesemael, Tineke J.
Hoogslag, Anna Titia W.
Borggreven, Nicole V.
Huizinga, Tom W. J.
van der Helm-van, Annette H. M.
Toes, René E. M.
van der Woude, Diane
Trouw, Leendert A.
Source :: RMD Open; Dec2023, Vol. 9 Issue 4, p1-11, 11p
Publication Year :: 2023

Full Text Access

Tools